GPhC responds to planned appeal on Avastin
We have launched a consultation on our proposals to increase the entry and yearly renewal fees for July 2019 to July 2020.
Please check our updated troubleshooting tips or before contacting us. These resources should answer your query.
The GPhC is reminding all pharmacy professionals of what they must do to ensure women and girls receive the right information about valproate and the risk of birth defects.
We are pleased to announce the names of the 544 pre-registration trainee pharmacists who passed their registration assessment in September.
The GPhC has issued a statement to give clarity to pharmacy professionals and patients and the public on the supply of the drug Avastin off licence for wet age-related macular degeneration (wet AMD).
Our website will not be available this evening from 7pm to 9pm due to essential maintenance. We are sorry for any inconvenience this may cause. This will not affect our other websites: or 
The GPhC Council agreed to begin a consultation in the coming month on an increase to some of its fees for 2019-20 at its meeting on 11 October 2018.
Our next council meeting takes place on Thursday 11 October 2018.
The GPhC welcomes the Professional Standards Authority’s (PSA) annual review of its performance for 2017/18.